Skip to main content
2025 AABB Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Event Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation Events
Foundation Events
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts
CABP Eligible
CABP Eligible
Video Recording

Educational Session

Transfusion Service

AM25-SN-06-L - Optimization of Postpartum Hemorrhage Management in the Academic and Community Setting

Sunday, October 26, 2025
8:15 AM - 9:15 AM  PT
Room: SDCC 31
CE: 1 CME (AMA Physician Credit) / 1 CE (Non-Physician Credit)

    Program Chair(s)

  • KO

    Kerry OBrien, MD

    Medical Director Blood Bank
    Beth Israel Deaconess Medical Center
    Topsfield, Massachusetts

    Disclosure(s): No financial relationships to disclose

    Handouts

    • Speaker(s)

  • SS

    Scott Shainker, DO, MS

    Director, New England Center for Placental Disorders / Associate Professor Obstetrics, Gynecology, and Reproductive Biology
    Beth Israel Deaconess Medical Center / Harvard Medical School, Massachusetts

    Disclosure(s): Chase Koch Foundation: Grant/Research Support (Ongoing); Healthcare Advances: Honoraria (Ongoing); Reckner Healthcare: Honoraria (Ongoing); Roche Pharmaceutical and Diagnostic Advisory Board: Consultant/Advisory Board (Terminated)

    Handouts

  • Tara Singh, MD, MHCDS (she/her/hers)

    Chief of Obstetrics and Gynecology
    Cambridge Health Alliance
    Cambridge, Massachusetts

    Disclosure(s): No financial relationships to disclose

    Handouts
Postpartum hemorrhage remains the leading, preventable cause of maternal morbidity and mortality worldwide. Representing over 27% of all maternal deaths, postpartum hemorrhage is the leading cause of maternal death worldwide. While identifiable risk factors for obstetric hemorrhage are well known, including multiple gestation, macrosomia, polyhydramnios, and uterine scarring, hemorrhage often occurs in the low risk patient. While tools exist to help identify patients at risk of postpartum hemorrhage, these events can happen in any location where births occur. Management of postpartum hemorrhage with blood products, medications, and surgical techniques has to be tailored and optimized for each delivery setting from the academic medical center to a community/rural hospital. Additionally transfers of hemorrhaging patients between echelons of care should occur in a way to ensure the receiving location is notified of the transfusions and medications given prior and during the transport. A maternal fetal-medicine specialist from an academic medical center and an obstetrician from a community hospital will discuss how they approach the patient with postpartum hemorrhage.

Learning Objectives:

  • Discuss the process of selecting the products and laboratory test values included within your facility's obstetric massive transfusion protocol.
  • Describe the methods for identifying risk factors for postpartum hemorrhage in the laboring patient in the academic setting and in the community.
  • Detail the blood product support and protocol for managing a hemorrhaging obstetric patient in the academic institution and how this is adapted for the community hospital.
  • Discuss how to optimize transfers of care of the hemorrhaging patient to ensure information on transfusions and medications are conveyed to the accepting institution